Clinical Trial Update: Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a novel therapy to preserve beta cell function in individuals with new-onset Type 1 diabetes was terminated, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diabetes Mellitus
• Type 1 Diabetes Mellitus

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus Type 1, Autoimmune Diabetes | Phase 2 | Status: TERMINATED | Results posted: 2012-10-24